133 related articles for article (PubMed ID: 21575476)
21. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
Kakinuma H; Bergert ER; Spitzweg C; Cheville JC; Lieber MM; Morris JC
Cancer Res; 2003 Nov; 63(22):7840-4. PubMed ID: 14633711
[TBL] [Abstract][Full Text] [Related]
22. Glycosylation of Sodium/Iodide Symporter (NIS) Regulates Its Membrane Translocation and Radioiodine Uptake.
Chung T; Youn H; Yeom CJ; Kang KW; Chung JK
PLoS One; 2015; 10(11):e0142984. PubMed ID: 26599396
[TBL] [Abstract][Full Text] [Related]
23. Sodium butyrate enhances the expression of baculovirus-mediated sodium/iodide symporter gene in A549 lung adenocarcinoma cells.
Guo R; Zhang Y; Liang S; Xu H; Zhang M; Li B
Nucl Med Commun; 2010 Oct; 31(10):916-21. PubMed ID: 20683361
[TBL] [Abstract][Full Text] [Related]
24. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.
Scholz IV; Cengic N; Baker CH; Harrington KJ; Maletz K; Bergert ER; Vile R; Göke B; Morris JC; Spitzweg C
Gene Ther; 2005 Feb; 12(3):272-80. PubMed ID: 15510175
[TBL] [Abstract][Full Text] [Related]
25. Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3).
Sieger S; Jiang S; Schönsiegel F; Eskerski H; Kübler W; Altmann A; Haberkorn U
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):748-56. PubMed ID: 12541134
[TBL] [Abstract][Full Text] [Related]
26. Gene therapy with sodium/iodide symporter in hepatocarcinoma.
Haberkorn U
Exp Clin Endocrinol Diabetes; 2001; 109(1):60-2. PubMed ID: 11573143
[TBL] [Abstract][Full Text] [Related]
27. The glial fibrillary acidic protein promoter directs sodium/iodide symporter gene expression for radioiodine therapy of malignant glioma.
Li W; Tan J; Wang P; Li N; Zhang F
Oncol Lett; 2013 Feb; 5(2):669-674. PubMed ID: 23420532
[TBL] [Abstract][Full Text] [Related]
28. Dual-expressing adenoviral vectors encoding the sodium iodide symporter for use in noninvasive radiological imaging of therapeutic gene transfer.
Niu G; Anderson RD; Madsen MT; Graham MM; Oberley LW; Domann FE
Nucl Med Biol; 2006 Apr; 33(3):391-8. PubMed ID: 16631088
[TBL] [Abstract][Full Text] [Related]
29. Tumor-targeted radionuclide imaging and therapy based on human sodium iodide symporter gene driven by a modified telomerase reverse transcriptase promoter.
Kim SH; Chung HK; Kang JH; Kim KI; Jeon YH; Jin YN; Yun CO; Chung JK
Hum Gene Ther; 2008 Sep; 19(9):951-7. PubMed ID: 18810799
[TBL] [Abstract][Full Text] [Related]
30. In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas.
Cho JY; Shen DH; Yang W; Williams B; Buckwalter TL; La Perle KM; Hinkle G; Pozderac R; Kloos R; Nagaraja HN; Barth RF; Jhiang SM
Gene Ther; 2002 Sep; 9(17):1139-45. PubMed ID: 12170377
[TBL] [Abstract][Full Text] [Related]
31. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
[TBL] [Abstract][Full Text] [Related]
32. Expression and activity of human Na+/I- symporter in human glioma cells by adenovirus-mediated gene delivery.
Cho JY; Xing S; Liu X; Buckwalter TL; Hwa L; Sferra TJ; Chiu IM; Jhiang SM
Gene Ther; 2000 May; 7(9):740-9. PubMed ID: 10822300
[TBL] [Abstract][Full Text] [Related]
33. In vivo long-term imaging and radioiodine therapy by sodium-iodide symporter gene expression using a lentiviral system containing ubiquitin C promoter.
Kim HJ; Jeon YH; Kang JH; Lee YJ; Kim KI; Chung HK; Jeong JM; Lee DS; Lee MC; Chung JK
Cancer Biol Ther; 2007 Jul; 6(7):1130-5. PubMed ID: 17611400
[TBL] [Abstract][Full Text] [Related]
34. [Study on combined gene therapy for malignant gliomas transfected with antisense hTERT/PTEN in vitro and in vivo].
You YP; Fu Z; Zhao P; Wang CZ; Liu N; Lu AL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):605-9. PubMed ID: 17160935
[TBL] [Abstract][Full Text] [Related]
35. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression.
Spitzweg C; Baker CH; Bergert ER; O'Connor MK; Morris JC
Hum Gene Ther; 2007 Oct; 18(10):916-24. PubMed ID: 17931047
[TBL] [Abstract][Full Text] [Related]
36. SPECT/CT imaging of hNIS-expression after intravenous delivery of an oncolytic adenovirus and 131I.
Rajecki M; Sarparanta M; Hakkarainen T; Tenhunen M; Diaconu I; Kuhmonen V; Kairemo K; Kanerva A; Airaksinen AJ; Hemminki A
PLoS One; 2012; 7(3):e32871. PubMed ID: 22412937
[TBL] [Abstract][Full Text] [Related]
37. Specific activation of sodium iodide symporter gene in hepatoma using alpha-fetoprotein promoter combined with hepatitis B virus enhancer (EIIAPA).
Liu RS; Hsieh YJ; Ke CC; Chen FD; Hwu L; Wang FH; Hwang JJ; Chi CW; Lee CH; Yeh SH
Anticancer Res; 2009 Jan; 29(1):211-21. PubMed ID: 19331152
[TBL] [Abstract][Full Text] [Related]
38. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
Ma XJ; Huang R; Kuang AR
Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193
[TBL] [Abstract][Full Text] [Related]
39. Feasibility of adenovirus-mediated hNIS gene transfer and 131I radioiodine therapy as a definitive treatment for localized prostate cancer.
Barton KN; Stricker H; Elshaikh MA; Pegg J; Cheng J; Zhang Y; Karvelis KC; Lu M; Movsas B; Freytag SO
Mol Ther; 2011 Jul; 19(7):1353-9. PubMed ID: 21587209
[TBL] [Abstract][Full Text] [Related]
40. Reversing the silencing of reporter sodium/iodide symporter transgene for stem cell tracking.
Kim YH; Lee DS; Kang JH; Lee YJ; Chung JK; Roh JK; Kim SU; Lee MC
J Nucl Med; 2005 Feb; 46(2):305-11. PubMed ID: 15695791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
